Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-25T01:51:29.272Z Has data issue: false hasContentIssue false
  • English
  • Français

Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia

Published online by Cambridge University Press:  03 September 2020

Majid M. Alshamrani ,
Aiman El-Saed ,
Azzam Mohammed ,
Majed F. Alghoribi ,
Sameera M. Al Johani ,
Harold Cabanalan  and
Hanan H. Balkhy
Majid M. Alshamrani*
Affiliation:
Infection Prevention and Control Department, King Abdulaziz Medical City (KAMC), Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Aiman El-Saed
Affiliation:
Infection Prevention and Control Department, King Abdulaziz Medical City (KAMC), Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia Community Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
Azzam Mohammed
Affiliation:
Infection Prevention and Control Department, King Abdulaziz Medical City (KAMC), Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia
Majed F. Alghoribi
Affiliation:
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia King Abdullah International Medical Research Center, MNGHA, Riyadh, Saudi Arabia
Sameera M. Al Johani
Affiliation:
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia Department of Pathology Medicine, KAMC, MNGHA, Riyadh, Saudi Arabia
Harold Cabanalan
Affiliation:
Infection Prevention and Control Department, King Abdulaziz Medical City (KAMC), Ministry of National Guard Health Affairs (MNGHA), Riyadh, Saudi Arabia
Hanan H. Balkhy
Affiliation:
Antimicrobial Resistance, World Health Organization
*
Author for correspondence: Majid Alshamrani, E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To describe local experience in managing an outbreak of Candida auris in a tertiary-care setting.

Methods:

In response to emerging Candida auris, an outbreak investigation was conducted at our hospital between March 2018 and June 2019. Once a patient was confirmed to have Candida auris, screening of exposed patients and healthcare workers (HCWs) was conducted. Postexposure screening included those who had had direct contact with or shared the same unit or ward with a laboratory-confirmed case. In response to the increasing number of cases, new infection control measures were implemented.

Results:

In total, 23 primary patients were detected over 15 months. Postexposure screening identified 11 more cases, and all were patients. Furthermore, ~28.6% of patients probably caught infection in another hospital or in the community. Infection control measures were strictly implemented including hand hygiene, personal protective equipment, patient hygiene, environmental cleaning, cohorting of patients and HCWs, and avoiding the sharing of equipment. The wave reached a peak in April 2019, followed by a sharp decrease in May 2019 and complete clearance in June 2019. The case patients were equally distributed between intensive care units (51.4%) and wards (48.6%). More infections (62.9%) occurred than colonizations (37.1%). Urinary tract infection (42.9%) and candidemia (17.1%) were the main infections. In total, 7 patients (20.0%) died during hospitalization; among them, 6 (17.1%) died within 30 days of diagnosis.

Conclusions:

Active screening of exposed patients followed by strict infection control measures, including environmental cleaning, was successful in ending the outbreak. Preventing future outbreaks is challenging due to outside sources of infection and environmental resistance.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 42 , Issue 2 , February 2021 , pp. 149 - 155
Check for updates
Copyright
© 2020 by The Society for Healthcare Epidemiology of America. All rights reserved.

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

de Cassia Orlandi Sardi, J, Silva, DR, Soares Mendes-Giannini, MJ, Rosalen, PL. Candida auris: epidemiology, risk factors, virulence, resistance, and therapeutic options. Microb Pathog 2018;125:116–121.CrossRefGoogle ScholarPubMed
Osei Sekyere, J. Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiol Open 2018;7(4):e00578.CrossRefGoogle Scholar
Cortegiani, A, Misseri, G, Fasciana, T, Giammanco, A, Giarratano, A, Chowdhary, A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris . J Intensive Care 2018;6:69.CrossRefGoogle ScholarPubMed
Forsberg, K, Woodworth, K, Walters, M, et al. Candida auris: the recent emergence of a multidrug-resistant fungal pathogen. Med Mycol 2019;57:1–12.CrossRefGoogle ScholarPubMed
Dudiuk, C, Berrio, I, Leonardelli, F, et al. Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris . J Antimicrob Chemother 2019;74:2295–2302.Google ScholarPubMed
Welsh, RM, Bentz, ML, Shams, A, et al. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic healthcare surface. J Clin Microbiol 2017;55:2996–3005.CrossRefGoogle ScholarPubMed
Short, B, Brown, J, Delaney, C, et al. Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence. J Hosp Infect 2019;103:92–96.CrossRefGoogle ScholarPubMed
Corsi-Vasquez, G, Ostrosky-Zeichner, L. Candida auris: what have we learned so far? Curr Opin Infect Dis 2019;32:559–564.CrossRefGoogle ScholarPubMed
Satoh, K, Makimura, K, Hasumi, Y, Nishiyama, Y, Uchida, K, Yamaguchi, H. Candida auris sp nov, a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 2009;53:41–44.CrossRefGoogle Scholar
Snyder, GM, Wright, SB. The epidemiology and prevention of Candida auris . Curr Infect Dis Rep 2019;21(6):19.CrossRefGoogle ScholarPubMed
Alfouzan, W, Dhar, R, Albarrag, A, Al-Abdely, H. The emerging pathogen Candida auris: a focus on the Middle-Eastern countries. J Infect Public Health. 2019;12:451–459.Google ScholarPubMed
Eyre, DW, Sheppard, AE, Madder, H, et al. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 2018;379:1322–1331.CrossRefGoogle Scholar
Ruiz-Gaitan, A, Martinez, H, Moret, AM, et al. Detection and treatment of Candida auris in an outbreak situation: risk factors for developing colonization and candidemia by this new species in critically ill patients. Expert Rev Anti Infect Ther 2019;17:295–305.CrossRefGoogle Scholar
Adams, E, Quinn, M, Tsay, S, et al. Candida auris in healthcare facilities, New York, USA, 2013–2017. Emerg Infect Dis 2018;24:1816–1824.CrossRefGoogle Scholar
Schelenz, S, Hagen, F, Rhodes, JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 2016;5:35.CrossRefGoogle Scholar
Abdalhamid, B, Almaghrabi, R, Althawadi, S, Omrani, A. First report of Candida auris infections from Saudi Arabia. J Infect Public Health 2018;11:598–599.CrossRefGoogle ScholarPubMed
Elsawy, A, Alquthami, K, Alkhutani, N, Marwan, D, Abbas, A. The second confirmed case of Candida auris from Saudi Arabia. J Infect Public Health 2019;12:907–908.CrossRefGoogle ScholarPubMed
Caceres, DH, Forsberg, K, Welsh, RM, et al. Candida auris: a review of recommendations for detection and control in healthcare settings. J Fungi (Basel). 2019;5(4):111.CrossRefGoogle ScholarPubMed
Hata, DJ, Humphries, R, Lockhart, SR. Candida auris: an emerging yeast pathogen posing distinct challenges for laboratory diagnostics, treatment, and infection prevention. Arch Pathol Lab Med 2020;144:107–114.CrossRefGoogle ScholarPubMed
Infection prevention and control for Candida auris. Centers for Disease Control and Prevention website. https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html. Updated 2019. Accessed January 10, 2020.Google Scholar
National Healthcare Safety Network (NHSN) patient safety component manual. Centers for Disease Control and Prevention website. https://www.cdc.gov/nhsn/pdfs/validation/2018/pcsmanual_2018-508.pdf. Published 2018. Accessed January 10, 2020.Google Scholar
Kumar, J, Eilertson, B, Cadnum, JL, et al. Environmental contamination with Candida species in multiple hospitals including a tertiary-care hospital with a Candida auris outbreak. Pathog Immun 2019;4:260–270.CrossRefGoogle ScholarPubMed
Biswal, M, Rudramurthy, SM, Jain, N, et al. Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. J Hosp Infect 2017;97:363–370.CrossRefGoogle ScholarPubMed
Escandon, P, Chow, NA, Caceres, DH, et al. Molecular epidemiology of Candida auris in Colombia reveals a highly related, countrywide colonization with regional patterns in amphotericin B resistance. Clin Infect Dis 2019;68:15–21.Google ScholarPubMed
Al Maani, A, Paul, H, Al-Rashdi, A, et al. Ongoing challenges with healthcare-associated Candida auris outbreaks in Oman. J Fungi (Basel) 2019;5(4). doi: 10.3390/jof5040101.Google ScholarPubMed
Ong, CW, Chen, SC, Clark, JE, et al. Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases. Intern Med J 2019;49:1229–1243.CrossRefGoogle ScholarPubMed
Armstrong, PA, Rivera, SM, Escandon, P, et al. Hospital-associated multicenter outbreak of emerging fungus Candida auris, Colombia, 2016. Emerg Infect Dis 2019;25:1339–1346.CrossRefGoogle ScholarPubMed
Spivak, ES, Hanson, KE. Candida auris: an emerging fungal pathogen. J Clin Microbiol 2018;56(2). doi: 10.1128/JCM.01588-17.Google ScholarPubMed